Researchers from a university in Italy explored whether a low carbohydrate approach could support breast cancer treatment. The findings suggested potential benefits of a reduced carb pattern in the context of breast cancer care, with results published in a nutrition-focused outlet. The study notes a shift toward fats as the primary energy source and a significant reduction in carbohydrate intake, a dietary approach that was historically considered for type 2 diabetes and certain seizure disorders in earlier decades.
Evidence indicates that the risk of breast cancer may rise with the consumption of highly processed foods of animal origin. Red meat, high-fat items, and carbohydrates can influence hormonal and inflammatory pathways by elevating circulating estrogen, inflammatory signaling molecules, and insulin-like growth factors. These factors are associated with cellular environments that can foster tumor development and progression.
Researchers sought to determine whether a low-carbohydrate dietary pattern could yield benefits for individuals facing breast cancer. They reviewed prior research on how reduced carbohydrate intake might interact with cancer biology and treatment responses.
Overall, the data suggest that a keto-style diet can alter tumor cell metabolism, potentially slowing growth. Lower carbohydrate intake can also reduce blood sugar fluctuations, which may impact signaling through insulin-like growth factor pathways. These metabolic shifts could contribute to slower tumor proliferation. In addition, a well-planned low-carbohydrate diet may help protect healthy cells from some treatment-related stressors, such as radiation and chemotherapy, by reducing collateral damage and supporting overall metabolic resilience.
The authors also highlighted that such a dietary approach might serve as an adjunct to conventional breast cancer therapies, rather than a stand-alone treatment. This means it could complement medical care by supporting metabolic management and patient well-being during therapy.
Separately, researchers in Russia have advanced methods aimed at predicting survival outcomes in lung cancer, underscoring a broader scientific effort to refine cancer prognostication and personalized care.